查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655419

全球神經血管支架市場

Neurovascular Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球神經血管支架市場將達到 34 億美元

2024 年全球神經血管支架市場規模估計為 19 億美元，預計 2030 年將達到 34 億美元，2024 年至 2030 年的複合年成長率為 9.7%。頸動脈支架是報告中分析的細分市場，預計其複合年成長率為 10.3%，到分析期結束時市場規模將達到 25 億美元。預計分析期內顱內支架段的複合年成長率為 8.0%。

美國市場規模估計為 5.487 億美元，中國市場預期複合年成長率為 9.0%

預計2024年美國神經血管支架市值將達5.487億美元。作為世界第二大經濟體的中國，預計到 2030 年市場規模將達到 5.115 億美元，2024-2030 年分析期間的複合年成長率為 9.0%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 8.7% 和 7.8%。在歐洲，預計德國的複合年成長率約為 7.7%。

全球神經血管支架市場 - 主要趨勢與促進因素摘要

什麼是神經血管支架？

神經血管支架是用於治療腦血管疾病的專用裝置，特別是用於預防和治療缺血性中風和動脈瘤。這些微小的網狀管被放置在腦血管內，以保持動脈暢通或將血流從動脈瘤轉移出去。在缺血性中風的情況下，血栓會阻塞流向大腦的血液，通常使用神經血管支架來恢復血流並防止永久性腦損傷。對於動脈瘤來說，分流支架可以有效地將血液引導出薄弱的血管壁，從而降低破裂的風險。

神經血管支架極為重要，因為它們可以對需要更具侵入性和風險的手術治療的疾病進行微創治療。支架在手術過程中和手術後支撐動脈壁並防止其崩壞的能力對於其有效性至關重要。這些支架的使用正在徹底改變中風管理，改善患者的治療效果，縮短恢復時間，並顯著降低中風復發和動脈瘤破裂的風險。

神經血管支架市場進展如何？

由於更複雜和專業的支架設計的發展，神經血管支架市場正在快速發展。一個重要的趨勢是血流分流支架的興起，其在治療複雜的寬頸部動脈瘤方面變得越來越普遍。與傳統支架不同，血流分流器的工作原理是將血流從動脈瘤轉移出去，使血管隨著時間的推移而癒合。這項創新減少了多次手術的需要，並為曾經被認為無法手術的動脈瘤提供了更安全的選擇。

另一項重大進步是自動擴張型支架的發展。此支架的設計是為了適應患者血管的獨特形狀。這些支架可以更精確地部署，並且不太可能對動脈造成創傷。此外，生物可吸收支架越來越受歡迎，這種支架在達到其作用後會逐漸溶解。這些支架降低了與永久植入相關的長期風險，對於年輕患者和因傳統金屬支架而面臨併發症風險較高的患者尤其有益。

哪些疾病推動了神經血管支架的採用？

神經血管支架的採用主要是為了治療缺血性中風和腦動脈瘤。在缺血性中風中，當血栓阻塞流向大腦的血液時，血栓摘取支架對於恢復血流和防止長期殘疾或死亡至關重要。這些裝置可以機械地去除血栓並重新打開阻塞的動脈，顯著改善患者的治療效果。神經血管支架也用於治療頸動脈狹窄。頸動脈狹窄是一種頸動脈變窄的疾病，會限制流向大腦的血液並增加中風的風險。

腦動脈瘤是推動支架應用的另一個重要疾病。流量轉移支架用於治療傳統栓塞技術難以治療的寬頸或大型動脈瘤。這些支架提供了一種微創解決方案，可降低動脈瘤破裂的風險並使血管隨著時間的推移而癒合。此外，神經血管支架也用於治療動靜脈畸形（AVM）等血管畸形，進一步擴大其在神經病學的應用。

推動神經血管支架市場成長的關鍵因素有哪些？

神經血管支架市場的成長受到多種因素的推動。缺血性中風和腦動脈瘤發生率的不斷增加，尤其是在老化人口中，是需求的主要驅動力。此外，人們對微創治療的日益偏好推動了神經血管支架的採用，因為它們比傳統手術提供了更安全、更快速、更有效的治療選擇。支架設計中的技術創新，例如流量轉移技術和生物可吸收材料，也透過提高這些設備的安全性和有效性推動了市場成長。

人們對中風預防和早期療育益處的認知不斷提高，加上政府採取措施降低中風相關死亡率，進一步推動了市場的發展。此外，醫學影像和即時導航技術的進步正在提高神經血管支架手術的精確度並改善患者的治療效果。新興市場的醫療保健基礎設施不斷擴大，也透過增加獲得先進神經血管治療的機會促進了市場的成長。

部分

產品類型（頸動脈支架、顱內支架）、最終用戶（醫院、門診手術中心）

受訪公司範例（值得關注的11家公司）

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • WL Gore & Associates

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13585

Global Neurovascular Stents Market to Reach US$3.4 Billion by 2030

The global market for Neurovascular Stents estimated at US$1.9 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Intracranial Stents segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$548.7 Million While China is Forecast to Grow at 9.0% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$548.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$511.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Neurovascular Stents Market - Key Trends & Drivers Summarized

What Are Neurovascular Stents and Why Are They Crucial in Stroke Management?

Neurovascular stents are specialized devices used to treat cerebrovascular conditions, particularly in the prevention and treatment of ischemic strokes and aneurysms. These small, mesh-like tubes are implanted in blood vessels in the brain to help keep arteries open or to redirect blood flow away from aneurysms. In cases of ischemic stroke, where blood clots block the flow of blood to the brain, neurovascular stents are often deployed to restore circulation and prevent permanent brain damage. For aneurysms, flow-diverting stents offer an effective way to redirect blood away from weakened vessel walls, reducing the risk of rupture.

Neurovascular stents are vital because they enable minimally invasive treatments for conditions that would otherwise require more invasive and higher-risk procedures. Their ability to support the artery walls and prevent collapse during and after the procedure is critical to their effectiveness. The use of these stents has revolutionized stroke management by improving patient outcomes, reducing recovery times, and significantly decreasing the risk of recurrent strokes or aneurysm ruptures.

How Is the Neurovascular Stents Market Advancing?

The neurovascular stents market is advancing quickly due to the development of more sophisticated and specialized stent designs. One of the key trends is the rise of flow-diverting stents, which are becoming increasingly popular for treating complex and wide-necked aneurysms. Unlike traditional stents, flow-diverters work by diverting blood flow away from the aneurysm, allowing the vessel to heal over time. This innovation reduces the need for multiple procedures and offers a safer alternative for aneurysms that were once considered inoperable.

Another significant advancement is in the development of self-expanding stents, which are designed to conform to the unique shape of the patient’s blood vessel. These stents can be deployed with greater precision and are less likely to cause trauma to the artery. Moreover, bioresorbable stents, which gradually dissolve after serving their purpose, are gaining traction. These stents reduce the long-term risks associated with permanent implants and are particularly beneficial in younger patients or those at higher risk for complications from traditional metal stents.

Which Conditions Are Driving the Adoption of Neurovascular Stents?

The adoption of neurovascular stents is primarily driven by the need to treat ischemic strokes and brain aneurysms. In ischemic strokes, where a blood clot obstructs blood flow to the brain, stent retrievers are critical in restoring circulation and preventing long-term disability or death. These devices allow for the mechanical removal of the clot and the reopening of the blocked artery, significantly improving patient outcomes. Neurovascular stents are also used in the treatment of carotid artery stenosis, a condition in which the carotid arteries narrow and restrict blood flow to the brain, increasing stroke risk.

Brain aneurysms are another key condition driving stent adoption. Flow-diverting stents are used to treat wide-necked or large aneurysms that are difficult to treat with traditional coiling techniques. These stents offer a minimally invasive solution that reduces the risk of aneurysm rupture and allows for vessel healing over time. Additionally, neurovascular stents are being used in treating vascular malformations such as arteriovenous malformations (AVMs), further expanding their applications in neurology.

What Are the Key Growth Drivers in the Neurovascular Stents Market?

The growth in the neurovascular stents market is driven by several factors. The increasing incidence of ischemic strokes and brain aneurysms, particularly among aging populations, is a primary driver of demand. Additionally, the growing preference for minimally invasive procedures is pushing the adoption of neurovascular stents, as they offer safer, faster, and more effective treatment options than traditional surgery. Technological innovations in stent design, such as flow-diversion technology and bioresorbable materials, are also fueling market growth by improving the safety and efficacy of these devices.

The rising awareness of stroke prevention and the benefits of early intervention, along with government initiatives to reduce stroke-related mortality, are further boosting the market. Moreover, advances in medical imaging and real-time navigation technologies are making neurovascular stent procedures more precise, enhancing patient outcomes. Expanding healthcare infrastructure in developing regions is also contributing to market growth by increasing access to advanced neurovascular treatments.

SCOPE OF STUDY:

The report analyzes the Neurovascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Carotid Artery Stents, Intracranial Stents); End-Use (Hospitals, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neurovascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Aneurysms Drives Demand for Neurovascular Stents in Minimally Invasive Treatments
    • Advancements in Stent Technology Propel Growth in Neurovascular Stents for Aneurysm Coiling and Clot Removal
    • Increasing Adoption of Flow Diversion Stents Expands Market for Aneurysm Management in Interventional Neurology
    • Growing Preference for Minimally Invasive Procedures Strengthens Demand for Neurovascular Stents in Stroke Treatment
    • Technological Innovations in Retrievable and Fully-Deployable Stents Accelerate Adoption in Complex Neurovascular Cases
    • Rising Use of Drug-Eluting Stents for Neurovascular Applications Expands Opportunities for Improved Patient Outcomes
    • Expansion of Stent-Assisted Coiling in Aneurysm Procedures Generates New Demand for Hybrid Neurovascular Devices
    • Increasing Focus on Patient-Specific Stents and Customized Solutions Drives Growth in Personalized Neurovascular Interventions
    • Growing Adoption of Bioabsorbable Stents Strengthens Market for Next-Generation Neurovascular Devices
    • Rising Prevalence of Cerebral Aneurysms in Aging Populations Expands Market for Neurovascular Stents in Elderly Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of World 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of World 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION